학술논문

Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease
Document Type
Article
Source
In: Journal of Gastroenterology and Hepatology (Australia). (Journal of Gastroenterology and Hepatology (Australia), September 2023, 38(9):1503-1509)
Subject
Language
English
ISSN
14401746
08159319